Mark Hyman possesses extensive experience in intellectual property law, particularly in the pharmaceutical sector. From May 2019 to January 2024, Mark served as the Vice President of Pharmaceutical Patents at AbbVie, leading the development and implementation of IP strategies for immunology therapeutics while managing a substantial IP portfolio. Prior to AbbVie, Mark worked at Human Genome Sciences from January 2001 to January 2013 as Assistant General Counsel for Litigation & IP, where responsibilities included managing IP and litigation matters for key antibody products and advising senior management. Mark's earlier roles encompassed various positions at Pennie & Edmonds and Rosenblatt & Redano, focused on patent application preparation, prosecution, and litigation support. Mark earned a J.D. from the University of Houston Law Center after completing studies at Baylor College of Medicine.
This person is not in any teams
This person is not in any offices